A Study of Inactivated Swine-Origin A/H1N1 Influenza Vaccines in Healthy European Subjects Aged 3 to 17 Years

NCT00956202 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Swine-origin A/H1N1 Influenza

Interventions

BIOLOGICAL: Swine A/H1N1 influenza vaccine (split virion, inactivated)
BIOLOGICAL: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)
BIOLOGICAL: Swine A/H1N1 influenza vaccine (split virion, inactivated + Adjuvant)

Sponsor

Sanofi Pasteur, a Sanofi Company